[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-351872-105":59,"doc-detail-351872-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","from-innate-immunity-to-cancer-therapy-antimicrobial-peptides-as-emerging-anticancer-agents-review","From Innate Immunity to Cancer Therapy - Antimicrobial Peptides as Emerging Anticancer Agents - Review","","Antimicrobial peptides (AMPs) are attracting strong attention as anticancer agents due to their selective cytotoxicity toward tumor cells and their capacity to evade multidrug resistance. As short cationic amphiphilic molecules of the innate immune system, AMPs act through direct membrane disruption and immunomodulatory signaling. Anticancer peptides (ACPs) can be sourced naturally or engineered, exploiting distinct biophysical features of cancer membranes. Peptide engineering and nanocarriers aim to enhance stability, bioavailability, and targeted delivery, while preclinical and clinical studies suggest immunogenic cell death and tumor microenvironment modulation. Key barriers include proteolytic degradation, dose-related toxicity, production costs, and regulatory hurdles.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/from-innate-immunity-to-cancer-therapy-antimicrobial-peptides-as-emerging-anticancer-agents-review/351872/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/from-innate-immunity-to-cancer-therapy-antimicrobial-peptides-as-emerging-anticancer-agents-review/351872.png","ImageObject",300,407,{"name":92,"@type":93},"Franzy","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-07","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why are antimicrobial peptides considered promising anticancer agents?","Question",{"text":112,"@type":113},"AMPs show selective cytotoxicity toward tumor cells and can evade multidrug resistance. They can also disrupt cancer cell membranes and modulate immune responses.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How can anticancer peptides be obtained or improved for cancer therapy?",{"text":117,"@type":113},"ACPs may be derived from natural sources or synthetically engineered. Engineering approaches such as D-amino acid substitution, cyclization, and PEGylation, together with nanocarrier delivery, aim to improve stability, bioavailability, and targeted delivery.",{"name":119,"@type":110,"acceptedAnswer":120},"What challenges limit the clinical translation of AMPs/ACPs?",{"text":121,"@type":113},"Major challenges include proteolytic degradation, dose-dependent toxicity, production costs, and regulatory hurdles.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},351872,1790193692,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},2336478945519,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Review  \nFrom Innate Immunity to Cancer Therapy: Antimicrobial Peptides as Emerging Anticancer Agents  \nNeha Raut 1, Saeed Vohra 2, Pooja Kaushalye 1, Sainath Mane 1, Divya Malode 1, Milind Umekar 3, Abdulrahman Mohammed Alhudhaibi 4, Anis Ahmad Chaudhary 4 and Rashmi Trivedi 1, *  \nAcademic Editor: Sonia Melino  \nReceived: 11 May 2026  \nRevised: 24 May 2026  \nAccepted: 2 June 2026  \nPublished: 8 June 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Department of Quality Assurance, Smt. Kishoritai Bhoyar College of Pharmacy, Kamptee, Nagpur 441002, India; [kaushalyepooja@gmail.com](kaushalyepooja@gmail.com) (P.K.)  \n2 Department of Anatomy and Physiology, College of Medicine, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh 11623, Saudi Arabia  \n3 Department of Pharmaceutics, Smt. Kishoritai Bhoyar College of Pharmacy, Nagpur 441002, India  \n4 Department of Biology, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh 11623, Saudi Arabia  \n* Correspondence: [rashmitrivedimishra@gmail.com or hr@skb.edu.in](rashmitrivedimishra@gmail.com or hr@skb.edu.in)  \nAbstract  \nThe potential for the use of antimicrobial peptides (AMPs) as anticancer agents has garnered much interest because of their selective cytotoxicity to tumor cells and ability to evade multidrug resistance mechanisms. AMPs are shorter cationic amphiphilic molecules, part of our innate immune system, with direct membrane-disruptive activity and immunomodulatory effects. Anticancer peptides (ACPs) can be derived from natural biophysical sources or synthetically engineered, taking advantage of the unique biophysical properties of cancer cell membranes to exert their anti-tumor activities rapidly and often without significant effects on normal tissues. Advances in peptide engineering, such as D-amino acid substitution, cyclization, and PEGylation, combined with nanocarrier systems, have provided opportunities to improve peptide stability, bioavailability, and delivery to targeted sites. Studies in preclinical and clinical models show promise, indicating that AMPs and ACPs can induce immunogenic cell death, modify tumor microenvironments, and be used in combination with more conventional therapies. While the promise of AMPs and ACPs as relatively novel cancer therapeutics is substantial, challenges such as proteolytic degradation, dose-dependent toxicity, costs for production, and regulatory hurdles are notable. This review organizes the current literature on classification, mechanism(s) of action, delivery strategies, preclinical and clinical data, and provides areas for future work to improve and help speed their clinical translation as new cancer therapies.  \nKeywords: antimicrobial peptides; anticancer peptides; cancer therapy; immunogenic cell death; nanocarrier delivery  \n1. Introduction  \nCancer is increasingly becoming a severe public health problem and is expected to impose an enormous and massive strain on the world. In 2022, cancer was reported in a projected 20 million people globally, and 9.7 million cancer deaths were recorded in the same year. The number of new cancer instances per year is expected to grow to more than 35 million by 2050 because of an increase in population, aging, and lifestyle-related cancer risks [1] . The reasons behind this trend include aging populations, changes in lifestyles, and  \nthe presence of cancers related to persistent infection, especially in resource-poor countries. Strategies for avoidance are essential to counteract this problem [1] .  \nMany aspects influence cancer development, including infections, genetics, dietary routines, hormonal imbalances, and immune status. However, traditional treatments (surgical interventions, chemotherapy, and radiation therapy) are not specific enough, hence influencing healthy tissue along wit","cbCaidM4qsGklNtE","https://ap.wps.com/l/cbCaidM4qsGklNtE","pdf",1829792,26,"English","# Abstract\n# Keywords\n# 1. Introduction","[{\"question\":\"Why are antimicrobial peptides considered promising anticancer agents?\",\"answer\":\"AMPs show selective cytotoxicity toward tumor cells and can evade multidrug resistance. They can also disrupt cancer cell membranes and modulate immune responses.\"},{\"question\":\"How can anticancer peptides be obtained or improved for cancer therapy?\",\"answer\":\"ACPs may be derived from natural sources or synthetically engineered. Engineering approaches such as D-amino acid substitution, cyclization, and PEGylation, together with nanocarrier delivery, aim to improve stability, bioavailability, and targeted delivery.\"},{\"question\":\"What challenges limit the clinical translation of AMPs/ACPs?\",\"answer\":\"Major challenges include proteolytic degradation, dose-dependent toxicity, production costs, and regulatory hurdles.\"}]","From Innate Immunity to Cancer Therapy - Antimicrobial Peptides as Emerging Anticancer Agents - Review | PDF",1790096365,66,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/51bd250521594708c6cefaa09a9d9dcf.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0020260ba1627107971f9635604d26ec.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e057e7770b8cd820616d33959ff442a3.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/727d012dea741ecc432f0cd2b481e3a0.webp",980,1385]